LEXXW Lexaria Bioscience Corp. - Warrant
Lexaria Bioscience Corp. operates in the drug delivery platform business. It develops and out-licenses its DehydraTECH technology for the delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing, and higher effectiveness in active molecule delivery. The company has licensed DehydraTECH to various companies operating in the nicotine, pharmaceutical, nutraceutical, and vitamin industries. Lexaria Bioscience Corp. was founded in 2004 and is headquartered in Kelowna, Canada. This security was issued by Lexaria Bioscience Corp., whose common stock symbol is LEXX.
$0.80 +0.15 (23.08%)
As of 03/17/2023 16:00:00 EST IEX book CBOE book
Security Information
Category1: US Equity
Category2: Warrants
Category3: Operating Companies
GICS sector: Health Care
Industry: Packaged Foods
Index country: Canada
Country of incorporation:
IPO date: 01/12/2021
Outstanding shares: 1,066,666
Average volume: 1,463
Market cap: $15,323,264
Current dividend yield: 0.00%
All SEC filings: SEC Edgar Online
Quarterly filings: 10-Q
Annual filings: 10-K
Sedol: